Phase 1, Randomised Double Blinded Placebo Controlled Study of ASLAN003

Clinical trial NCT01992367 · COMPLETED

Trial details

NCT number: NCT01992367
Sponsor: ASLAN Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2013-08-01
Primary completion: 2014-05-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.